P-286Metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel (nab-P), bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer (MPC): an open-label, multicenter, single-arm, phase 1/2 study

ABSTRACT:

SUBMITTER: Vincent P 

PROVIDER: S-EPMC4984073 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature